Skip to main content

Table 4 Pooled prevalence of psychiatric disorders among chronic urticaria (CU) patients, categorized according to Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (data listed for disorders referred in at least two different published articles)

From: Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis

DSM-5 classification

Patients

N/all CU patients

Controla

N/all healthy controls

p-value*

Prevalence per study

Pooled prevalence (%)

Prevalence per study

Pooled prevalence (%)

Sleep–wake disorders (e.g., insomnia disorder, restless legs syndrome)

57/110 [24]

31/130 [35]

88/240 (36.7%)

12/100 [35]

(12%) based only of ref. [35]

< 0.001

Anxiety disorders (e.g. generalized anxiety disorder, phobias)

30/100 [22]

2/50 [23]

48/110 [24]

24/30 [25]

39/89 [26]

25/100 [27]

10/84 [28]

4/31 [31]

15/50 [34]

197/644 (30.6%)

13/30 [25]

7/64 [26]

20/94 (21.3%)

0.16b

Mood disorders (major depressive disorder, dysthymic disorder)

12/20 [19]

17/100 [22]

16/50 [23]

39/110 [24]

15/30 [25]

18/89 [26]

11/100 [27]

36/84 [28]

6/31 [31]

23/50 [34]

2/3 [36]

195/664 (29.4%)

5/30 [25]

3/64 [26]

8/94 (8.5%)

0.001

Trauma and stressor-related disorders (e.g. posttraumatic stress disorder, adjustment disorder)

5/100 [22]

1/31 [31]

34/100 [32]

40/231 (17.3%)

–

–

–

Somatic symptom and related disorders (e.g., somatic symptom disorder, conversion disorder)

17/100 [22]

21/30 [25]

11/100 [27]

5/84 [28]

54/314 (17.2%)

12/30 [25]

(40%) based only of ref. [25]

0.020 c

Obsessive–compulsive and related disorders

4/100 [22]

1/50 [23]

3/110 [24]

23/89 [26]

3/31 [31]

2/7 [33]

36/387 (9.3%)

1/64 [26]

(1.6%) based only of ref. [26]

0.045

Substance-related and addictive disorders (e.g., alcohol use disorder)

5/100 [22]

1/50 [23]

6/150 (4%)

–

–

–

  1. N number of patients with psychiatric disorders
  2. *Comparisons based on Pearson’s χ2
  3. aOnly studies comparing the prevalence of psychiatric disorders in CU patients and healthy controls are listed
  4. bNon-statistically significant result attributed to the high prevalence of psychiatric entities among control group in reference 25 (46.6%)
  5. cStatistically significant result attributed to the high prevalence of psychiatric entities among control group in reference 25 (46.6%)